Key facts
- It has raised $110K across 1 recorded rounds; the latest was Seed Round ($3.0M) in May 2026.
- Notable investors include Creative Destruction Lab.
- Vivamed has filed 1 Form D with the SEC, most recently May 2025 ($110K sold to 4 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vivamed
Funding rounds
1 roundsAbout Vivamed
Developer of an integrated sleep-health platform designed to address obstructive sleep apnea. The company's platform provides real-time sleep data, adaptive therapy support, and streamlined diagnostic pathways, enabling patients and clinicians to manage obstructive sleep apnea with greater accuracy, comfort, and long-term adherence to treatment.
- Sector
- Healthcare
- HQ
- Santa Monica, CA, United States
- Founded
- 2024
- Website
- vivamedinc.com/
- Ownership
- Privately Held (backing)
Vivamed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vivamed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vivamed in its N-PORT filings yet. We sweep new filings monthly.